N-substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo

C. Anil Kumar, S. Nanjunda Swamy, S. L. Gaonkar, Basappa, Bharathi P. Salimath, Kanchugarakoppal S. Rangappa

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

A new series of N-substituted 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives were synthesized by using the different bioactive heteroaralkyl halides with 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde in presence of powdered potassium carbonate in DMF medium. These compounds were screened for their antitumor activity. Our results show that treatment of imidazole derivatives inhibit proliferation EAT cells, decreases the ascites volume and increases the survivability of the animals in vivo. These compounds also inhibited the cellular proliferation of HUVEC cells in vitro by MTT assay. Further, these compounds could induce apoptosis, which is evident by the nuclear condensation of imidazole derivatives treated EAT cells in vivo by the cytological analysis. We have identified that pyrrolidine substituted imidazole derivative as potent anti-tumor compound. These inhibitors could represent as promising candidates for anticancer therapies, where the formation of peritoneal malignant ascites is a major cause of morbidity and mortality.

Original languageEnglish
Pages (from-to)269-276
Number of pages8
JournalMedicinal Chemistry
Volume3
Issue number3
DOIs
Publication statusPublished - 05-2007

Fingerprint

Ehrlich Tumor Carcinoma
Neoplasms
Ascites
Cell Proliferation
Human Umbilical Vein Endothelial Cells
imidazole
Apoptosis
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Drug Discovery

Cite this

Anil Kumar, C. ; Nanjunda Swamy, S. ; Gaonkar, S. L. ; Basappa ; Salimath, Bharathi P. ; Rangappa, Kanchugarakoppal S. / N-substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo. In: Medicinal Chemistry. 2007 ; Vol. 3, No. 3. pp. 269-276.
@article{5d53659e71f7444fa842b886ab66f477,
title = "N-substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo",
abstract = "A new series of N-substituted 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives were synthesized by using the different bioactive heteroaralkyl halides with 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde in presence of powdered potassium carbonate in DMF medium. These compounds were screened for their antitumor activity. Our results show that treatment of imidazole derivatives inhibit proliferation EAT cells, decreases the ascites volume and increases the survivability of the animals in vivo. These compounds also inhibited the cellular proliferation of HUVEC cells in vitro by MTT assay. Further, these compounds could induce apoptosis, which is evident by the nuclear condensation of imidazole derivatives treated EAT cells in vivo by the cytological analysis. We have identified that pyrrolidine substituted imidazole derivative as potent anti-tumor compound. These inhibitors could represent as promising candidates for anticancer therapies, where the formation of peritoneal malignant ascites is a major cause of morbidity and mortality.",
author = "{Anil Kumar}, C. and {Nanjunda Swamy}, S. and Gaonkar, {S. L.} and Basappa and Salimath, {Bharathi P.} and Rangappa, {Kanchugarakoppal S.}",
year = "2007",
month = "5",
doi = "10.2174/157340607780620699",
language = "English",
volume = "3",
pages = "269--276",
journal = "Medicinal Chemistry",
issn = "1573-4064",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

N-substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo. / Anil Kumar, C.; Nanjunda Swamy, S.; Gaonkar, S. L.; Basappa; Salimath, Bharathi P.; Rangappa, Kanchugarakoppal S.

In: Medicinal Chemistry, Vol. 3, No. 3, 05.2007, p. 269-276.

Research output: Contribution to journalArticle

TY - JOUR

T1 - N-substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo

AU - Anil Kumar, C.

AU - Nanjunda Swamy, S.

AU - Gaonkar, S. L.

AU - Basappa,

AU - Salimath, Bharathi P.

AU - Rangappa, Kanchugarakoppal S.

PY - 2007/5

Y1 - 2007/5

N2 - A new series of N-substituted 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives were synthesized by using the different bioactive heteroaralkyl halides with 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde in presence of powdered potassium carbonate in DMF medium. These compounds were screened for their antitumor activity. Our results show that treatment of imidazole derivatives inhibit proliferation EAT cells, decreases the ascites volume and increases the survivability of the animals in vivo. These compounds also inhibited the cellular proliferation of HUVEC cells in vitro by MTT assay. Further, these compounds could induce apoptosis, which is evident by the nuclear condensation of imidazole derivatives treated EAT cells in vivo by the cytological analysis. We have identified that pyrrolidine substituted imidazole derivative as potent anti-tumor compound. These inhibitors could represent as promising candidates for anticancer therapies, where the formation of peritoneal malignant ascites is a major cause of morbidity and mortality.

AB - A new series of N-substituted 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives were synthesized by using the different bioactive heteroaralkyl halides with 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde in presence of powdered potassium carbonate in DMF medium. These compounds were screened for their antitumor activity. Our results show that treatment of imidazole derivatives inhibit proliferation EAT cells, decreases the ascites volume and increases the survivability of the animals in vivo. These compounds also inhibited the cellular proliferation of HUVEC cells in vitro by MTT assay. Further, these compounds could induce apoptosis, which is evident by the nuclear condensation of imidazole derivatives treated EAT cells in vivo by the cytological analysis. We have identified that pyrrolidine substituted imidazole derivative as potent anti-tumor compound. These inhibitors could represent as promising candidates for anticancer therapies, where the formation of peritoneal malignant ascites is a major cause of morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=34248674920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248674920&partnerID=8YFLogxK

U2 - 10.2174/157340607780620699

DO - 10.2174/157340607780620699

M3 - Article

C2 - 17504198

AN - SCOPUS:34248674920

VL - 3

SP - 269

EP - 276

JO - Medicinal Chemistry

JF - Medicinal Chemistry

SN - 1573-4064

IS - 3

ER -